Evidence map›Paper›PMID 32798440›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2020

[Research Advances and Obstacles of CT-based Radiomics in Diagnosis and Treatment of Lung Cancer].

Jiawei Li, Xiadong Li, Xueqin Chen, Shenglin Ma

Open access · greenAbstract readReview
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. [Progress in Diagnosis and Treatment of Lung Cancer Associated with Cystic Airspaces].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2023
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jiawei LiZhejiang Chinese Medical University, Hangzhou 310053, China.
Xiadong LiDepartment of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou 310002, China.
Xueqin ChenDepartment of Oncology, Hangzhou First People's Hospital, Hangzhou 310006, China.
Shenglin MaDepartment of Oncology, Hangzhou First People's Hospital, Hangzhou 310006, China.
Hangzhou First People's Hospital · CNHangzhou Cancer Hospital · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiomics, a technology based on multimodal medical image processing and analysis, is able to extract automatically and analyze massive data from computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT) via high-performance computer algorithm in order to pursue early diagnosis of disease, benign and malignant tumor discrimination, dynamic evaluation of disease treatment, and individualized precision therapy. To date, many studies demonstrate that radiomics not only has great potential in early diagnosis of lung cancer and prediction of genotype, treatment efficacy, as well as prognosis but also is based on imaging methods that are noninvasive, inexpensive, and repeatable. It does demonstrate precious values in guiding the clinical diagnosis and treatment of lung cancer, especially in the personalized and precise treatments and researches of lung cancer. However, the consistency and reproducibility of radiomics and the selection of robust characteristics still warrant further researches.
.

Indexed as

HumansLung NeoplasmsMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyTomography, X-Ray ComputedBiomarkersComputed TomographyLung neoplasmsPrognosisRadiomics

Identifiers

PMID32798440
PMCPMC7583873
OpenAlexW3080654267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.